Lv0
0 积分 2024-12-05 加入
Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial
9小时前
已完结
Efficacy and safety of immune checkpoint inhibitors for advanced or metastatic esophageal squamous cell carcinoma: A network meta-analysis
9小时前
已完结
Efficacy and Safety of Camrelizumab Plus Apatinib for Esophageal Squamous Cell Carcinoma
9小时前
已完结
皖公网安备34019202002308
